This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Berkshire Hathaway Buys More DaVita Stock (Update 1)

OMAHA, Neb. -- Warren Buffett's company bought more than 500,000 more shares of dialysis provider DaVita Inc.'s (DVA) stock last week after prices dropped because of fears of reduced Medicare payments.

The latest purchases reported to the Securities and Exchange Commission on Friday give Buffett's Berkshire Hathaway Inc. (BRK.A) (BRK.B) 15.6 million shares of DaVita's stock.

Berkshire now owns about 15 percent of DaVita, but it has agreed not to buy more than 25 percent of the Denver-based company unless, both companies agree.

DaVita runs nearly 2,000 outpatient dialysis clinics.

Berkshire has steadily increased its stake in DaVita over the past two years. Berkshire initially disclosed owning 2.7 million DaVita shares at the end of 2011.

DaVita's shares had gained nearly 10 percent this year before last week's proposed 9.4 percent rate cut from the Centers for Medicare and Medicaid Services.

Berkshire's investments in DaVita likely drove some of the interest in the stock because so many investors try to copy Buffett's moves.

Buffett has said that his investments tend to be the larger ones in Berkshire's portfolio. He says investments smaller than $300 million are likely to be the work of one of Berkshire's two other investment managers.

The final Medicare rates won't be determined until October, and any reduction in rates could be phased in over several years. But any reduction would likely cut DaVita's revenue because the company provides dialysis services to about 156,000 patients with chronic kidney failure and end-stage renal disease.

Copyright 2011 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
AAPL $124.75 0.00%
FB $80.78 0.00%
GOOG $524.05 0.00%
TSLA $206.79 0.00%
YHOO $44.45 0.00%

Markets

DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs